Treatment of Kawasaki Disease: A Network Meta-Analysis of Four Dosage Regimens of Aspirin Combined With Recommended Intravenous Immunoglobulin
Aspirin was once believed to reduce the mortality of Kawasaki disease (KD) due to its effect on the thrombotic occlusion of coronary arteries. However, conflicting evidence has been found regarding aspirin treatment and its benefit in patients with acute KD. We compared the efficacy of different asp...
Main Authors: | Ying-Hua Huang, Yi-Chen Hsin, Liang-Jen Wang, Wei-Ling Feng, Mindy Ming-Huey Guo, Ling-Sai Chang, Yu-Kang Tu, Ho-Chang Kuo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.725126/full |
Similar Items
-
Diagnosis of incomplete Kawasaki disease
by: Jeong Jin Yu
Published: (2012-03-01) -
Prediction of unresponsiveness to second intravenous immunoglobulin treatment in patients with Kawasaki disease refractory to initial treatment
by: Euri Seo, et al.
Published: (2016-10-01) -
Acute cholestasis as uncommon onset of Kawasaki disease: a case report
by: Massimo Gallerani, et al.
Published: (2020-10-01) -
Atypical Kawasaki Disease Presenting with Hemiparesis and Aphasia: A Case Report
by: Ali Nikkhah
Published: (2018-01-01) -
Enfermedad de Kawasaki: a propósito de un caso atípico y con intususcepción
by: Carlos Tori Tori, et al.
Published: (2001-01-01)